4.7 Article

SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease

Robert W. Schwenk et al.

CARDIOVASCULAR RESEARCH (2008)

Article Cardiac & Cardiovascular Systems

Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury

Kenneth R. McGaffin et al.

CARDIOVASCULAR RESEARCH (2008)

Article Biochemistry & Molecular Biology

A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia

Sanjay K. Banerjee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Medicine, General & Internal

Active sugar transport in health and disease

E. M. Wright et al.

JOURNAL OF INTERNAL MEDICINE (2007)

Review Physiology

Myocardial substrate metabolism in the normal and failing heart

WC Stanley et al.

PHYSIOLOGICAL REVIEWS (2005)

Article Biochemistry & Molecular Biology

Na+-D-glucose cotransporter in muscle capillaries increases glucose permeability

K Elfeber et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Biochemistry & Molecular Biology

Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)

LB Zhou et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2003)

Article Reproductive Biology

Aquaporin 9 expression along the male reproductive tract

N Pastor-Soler et al.

BIOLOGY OF REPRODUCTION (2001)